Keeping up with the ongoing stream of new study findings can be difficult for mere mortals, making artificial intelligence (AI) an important tool for clinicians aiming to keep abreast of the newest treatment options. According to Pubmed, about 50,000 papers on oncology are published each year, and the rate is expected to increase. Elekta Inc. and IBM Watson Health have inked a global deal to bring Watson for oncology's AI to its digital solutions in cancer care. One in six deaths worldwide are due to cancer, according to the WHO's 2017 Cancer Fact Sheet.